F13.931
Sedative, hypnotic or anxiolytic use, unspecified with withdrawal delirium
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F13.931 refers to a condition characterized by withdrawal delirium resulting from the use of sedatives, hypnotics, or anxiolytics. These medications are often prescribed to manage anxiety, sleep disorders, or other conditions, but misuse or sudden discontinuation can lead to serious withdrawal symptoms. Withdrawal delirium is a neuropsychiatric condition marked by confusion, hallucinations, and disturbances in consciousness, typically occurring when a person dependent on these substances stops or reduces their intake abruptly. Recognizing and understanding this condition is crucial for appropriate management and recovery.
Causes & Symptoms
Clinical Causes: Prolonged or excessive use of sedative, hypnotic, or anxiolytic medications Sudden cessation or reduction of medication dosage in dependent individuals Inadequate tapering procedures during medication discontinuation Misuse or abuse of prescribed medications Underlying health conditions that increase susceptibility to withdrawal symptoms
Key Symptoms: Confusion or disorientation Visual or auditory hallucinations Agitation or restlessness Fluctuations in consciousness levels Rapid eye movements or pupil changes Sweating or tremors Difficulty focusing or concentrating Potential seizures in severe cases Sleep disturbances or insomnia
Diagnostic & Treatment
Diagnosis Path: Diagnosis is primarily clinical, based on a detailed medical history of sedative, hypnotic, or anxiolytic use and abrupt changes in intake. Healthcare providers evaluate symptoms indicative of delirium, such as altered mental status, hallucinations, and cognitive disturbances. Laboratory tests and toxicology screens may support the diagnosis by identifying the presence of substances or metabolic disturbances. In some cases, neuroimaging studies might be performed to rule out other causes of delirium.
Treatment Protocols: Managing withdrawal delirium involves supportive and symptomatic care, including monitoring vital signs and mental status. Medications such as benzodiazepines may be used cautiously to control agitation and prevent seizures. Ensuring a safe environment reduces the risk of injury. Gradual tapering of sedative, hypnotic, or anxiolytic medications under medical supervision can help prevent recurrence. Additionally, addressing underlying psychiatric conditions, providing psychological support, and considering long-term treatment options for substance dependence are essential components of care.
Clinical Advice & FAQs
Billing Guidance
Is F13.931 a billable ICD-10 code?
Yes, F13.931 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F13.931?
Clinical documentation must specify the nature of Sedative, hypnotic or anxiolytic use, unspecified with withdrawal delirium and any associated comorbidities for accurate reporting.
Cite this Clinical Reference